View More Recent Stories
-
FTC Releases Second Interim Staff Report on Prescription Drug Middlemen
-
House Republicans Are Eyeing A Package To Extend Govt Funding For Three Months - Punchbowl
-
Trump on drug industry: We're going to knock out the middle man
-
Bernstein Comments on Senators' Proposal to Break Up PBMs; UNH, CVS, CI Stocks Down 5-6%
-
Cigna Corp. (CI) call put ratio 1 call to 1.3 puts with focus on January calls and puts as share price down 5.2%
-
Bipartisan Legislation To Be Introduced to Force Health Insurers to Give Up Pharmacy Businesses -- WSJ
-
Cigna Corp. (CI) call put ratio 1.6 calls to 1 put with focus on January 340 calls
-
Is Trump 2.0 good or bad for healthcare stocks?
-
Trump picks RFK Jr for HHS — Here are potential policy implications
-
Cigna Corp. (CI) is not pursuing a combination with Humana (HUM)
-
CIGNA (CI) PT Raised to $394 at Piper Sandler
-
CIGNA (CI) PT Lowered to $406 at Jefferies
-
Cigna Corp. (CI) Tops Q3 EPS by 28c; offers guidance
-
Cigna Corp. (CI) call put ratio 11.3 calls to 1 put into quarter results
-
Deutsche Bank Reiterates Hold Rating on Humana (HUM)
-
Cigna Corp. (CI) options active on 4K contracts
-
Centene (CNC) on watch on vague chatter
-
Cigna Corp. (CI) Is Said To Resume Merger Discussions With Humana (HUM) - Bloomberg
-
Attorney General Ken Paxton Sues Big Pharma Drug Manufacturers and Pharmacy Benefit Managers for Conspiracy That Increased Insulin Prices by 1,000%
-
Humana (HUM) Sinks After Issuing Update on Medicare Advantage Plans for 2025
-
Bernstein SocGen Group Reiterates Outperform Rating on CIGNA (CI)
-
Bernstein SocGen Group Reiterates Outperform Rating on CIGNA (CI)
-
Cigna Corp. (CI): Express Scripts Comments on FTC's Reckless Insulin Action
-
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
-
Cigna's (CI) Express Scripts Sues FTC, Demands Withdrawal of PBM Report
-
CIGNA (CI) PT Raised to $422 at Jefferies
-
Cigna Corp. (CI) Tops Q2 EPS by 29c; offers guidance
-
FTC to Sue Drug Managers over Insulin Prices - WSJ
-
Piper Sandler Starts CIGNA (CI) at Overweight
-
Medicare Advantage Plans Quality Ratings To Be Recalculated - WSJ

